Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis
Fig 9
Model of independent and co-existing TP53 and ARID1A mutations in endometrial epithelia.
Summary of endometrial disease features and hypothesized molecular mechanisms in genetically engineered mouse models from this study.